Literature DB >> 469266

The occurrence and treatment of false positive reactions in enzyme-linked immunosorbent assays (ELISA) for the presence of fungal antigens in clinical samples.

R C Warren, L O White, S Mohan, M D Richardson.   

Abstract

Non-specific positive reactions have been revealed in enzyme-linked immunosorbent assays (ELISA) of sera for the presence of fungal antigen. These false positives were recognized by their occurrence in tests for both Candida albicans and Aspergillus fumigatus antigens and by their response to dithiothreitol, combined with their reaction with non-immune rabbit globulin. A scheme is proposed which differentiates between true and false positive reactions. Use of fractionated anti-fungal globulin in conjugates reduced the incidence of false positive results in sera from hospitalized patients and eliminated them from sera of healthy subjects. The test scheme was applied to two panels of sera containing samples from patients with (a) invasive candidosis and (b) invasive aspergillosis. The relevance of ELISA tests for the detection of fungal antigen in human serum is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 469266     DOI: 10.1016/0022-1759(79)90339-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Comparison of immunoperoxidase plaque staining and neutralizing tests for canine distemper virus.

Authors:  T Soma; H Ishii; M Hara; S Yamamoto; T Yoshida; T Kinoshita; K Nomura
Journal:  Vet Res Commun       Date:  2001-05       Impact factor: 2.459

2.  Sero-diagnosis of invasive aspergillosis: attempts to determine antigen and antibody relevance to infection.

Authors:  S B Mohan; R C Warren; M D Richardson
Journal:  Mycopathologia       Date:  1980-02-29       Impact factor: 2.574

3.  Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay.

Authors:  W M Scheld; R S Brown; S A Harding; M A Sande
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.